Leaderships of the Samsung’s biopharmaceutical business, Han-seung Ko and Tae-han Kim

Published: 2015-09-24 14:21:17

Updated: 2015-09-24 14:21:17

Samsung Bioepis and Samsung Biologics are observed to successfully settle down in the market in 4 years of their launches.

Samsung selected biopharmaceutical as one of the top 5 new growth powers along with LED(light emitting diode), batteries for vehicles and solar batteries in 2012, but there were skeptical responses internally and externally due to its inexperience in the business.

However...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.